The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis

被引:29
作者
Shao, Chen [2 ,3 ]
Zhao, Lijing [2 ]
Wang, Ke [1 ]
Xu, Wei [1 ]
Zhang, Jie [1 ]
Yang, Baoxue [2 ,4 ]
机构
[1] Jilin Univ, Affiliated Hosp 2, Dept Resp Med, Changchun 130041, Jilin, Peoples R China
[2] Jilin Univ, Norman Bethune Coll Med, Dept Pathophysiol, Changchun 130021, Jilin, Peoples R China
[3] Jilin Univ, China Japan Union Hosp, Dept Digest Med, Changchun 130033, Jilin, Peoples R China
[4] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
RBM5; Lung adenocarcinoma; Apoptosis; A549; Xenograft mice model; CD95-MEDIATED APOPTOSIS; HOMOZYGOUS DELETION; CHROMOSOME; 3P21.3; CANCER CELLS; IN-VITRO; REGION; RNA; EPIDEMIOLOGY; COEXPRESSION; METASTASIS;
D O I
10.1186/1477-7819-10-160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The loss of tumor suppressor gene (TSG) function is a critical step in the pathogenesis of human lung cancer. RBM5 (RNA-binding motif protein 5, also named H37/LUCA-15) gene from chromosome 3p21.3 demonstrated tumor suppressor activity. However, the role of RBM5 played in the occurrence and development of lung cancer is still not well understood. Method: Paired non-tumor and tumor tissues were obtained from 30 adenocarcinomas. The expression of RBM5 mRNA and protein was examined by RT-PCR and Western blot. A549 cell line was used to determine the apoptotic function of RBM5 in vitro. A549 cells were transiently transfected with pcDNA3.1-RBM5. AnnexinV analysis was performed by flow cytometry. Expression of Bcl-2, cleaved caspase-3, caspase-9 and PAPP proteins in A549 lung cancer cells and the A549 xenograft BALB/c nude mice model was determined by Western blot. Tumor suppressor activity of RBM5 was also examined in the A549 xenograft model treated with pcDNA3.1-RBM5 plasmid carried by attenuated Salmonella typhi Ty21a. Result: The expression of RBM5 mRNA and protein was decreased significantly in adenocarcinoma tissues compared to that in the non-tumor tissues. In addition, as compared to the vector control, a significant growth inhibition of A549 lung cancer cells was observed when transfected with pcDNA3.1-RBM5 as determined by cell proliferation assay. We also found that overexpression of RBM5 induced both early and late apoptosis in A549 cells using AnnexinV/PI staining as determined by flow cytometry. Furthermore, the expression of Bcl-2 protein was decreased, whereas the expression of cleaved caspase-3, caspase-9 and PARP proteins was significantly increased in the RBM5 transfected cells; similarly, expression of decreased Bcl-2 and increased cleaved caspase-3 proteins was also examined in the A549 xenograft model. More importantly, we showed that accumulative and stable overexpression of RBM5 in the A549 xenograft BALB/c nude mice model significantly inhibited the tumor growth rate in vivo as compared to that in the control. Conclusion: Our study demonstrates that RBM5 can inhibit the growth of lung cancer cells and induce apoptosis both in vitro and in vivo, which suggests that RBM5 might be used as a potential biomarker or target for lung cancer diagnosis and chemotherapy. Moreover, we propose a novel animal model set up in BALB/c nude mice treated with attenuated Salmonella as a vector carrying plasmids to determine RBM5 function in vivo.
引用
收藏
页数:11
相关论文
共 33 条
[1]  
Akhtar MJ, 2012, ENV TOXICOL
[2]   Epidemiology of lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition) [J].
Alberg, Anthony J. ;
Ford, Jean G. ;
Samet, Jonathan M. .
CHEST, 2007, 132 (03) :29S-55S
[3]  
Angeloni Debora, 2007, Briefings in Functional Genomics & Proteomics, V6, P19, DOI 10.1093/bfgp/elm007
[4]   Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes [J].
Angeloni, Debora ;
ter Elst, Arja ;
Wei, Ming Hui ;
van der Veen, Anneke Y. ;
Braga, Eleonora A. ;
Klimov, Eugene A. ;
Timmer, Tineke ;
Korobeinikova, Luba ;
Lerman, Michael I. ;
Buys, Charles H. C. M. .
GENES CHROMOSOMES & CANCER, 2006, 45 (07) :676-691
[5]   SAFETY AND IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A VACCINE IN YOUNG THAI CHILDREN [J].
CRYZ, SJ ;
VANPRAPAR, N ;
THISYAKORN, U ;
OLANRATMANEE, T ;
LOSONSKY, G ;
LEVINE, MM ;
CHEARSKUL, S .
INFECTION AND IMMUNITY, 1993, 61 (03) :1149-1151
[6]   LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells [J].
Edamatsu, H ;
Kaziro, Y ;
Itoh, H .
GENES TO CELLS, 2000, 5 (10) :849-858
[7]   Targeting Zinc Finger Domains with Small Molecules: Solution Structure and Binding Studies of the RanBP2-Type Zinc Finger of RBM5 [J].
Farina, Biancamaria ;
Fattorusso, Roberto ;
Pellecchia, Maurizio .
CHEMBIOCHEM, 2011, 12 (18) :2837-2845
[8]   Synergistic Suppression of Prostatic Cancer Cells by Coexpression of Both Murine Double Minute 2 Small Interfering RNA and Wild-Type p53 Gene In Vitro and In Vivo [J].
Ji, Kun ;
Wang, Bo ;
Shao, Yue-ting ;
Zhang, Ling ;
Liu, Ya-nan ;
Shao, Chen ;
Li, Xiao-jie ;
Li, Xin ;
Hu, Jia-di ;
Zhao, Xue-jian ;
Xu, De-qi ;
Li, Yang ;
Cai, Lu .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01) :173-183
[9]   Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium [J].
Kimura, H. ;
Zhang, L. ;
Zhao, M. ;
Hayashi, K. ;
Tsuchiya, H. ;
Tomita, K. ;
Bouvet, M. ;
Wessels, J. ;
Hoffman, R. M. .
CELL PROLIFERATION, 2010, 43 (01) :41-48
[10]   p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5 [J].
Kobayashi, Takahiko ;
Ishida, Junich ;
Musashi, Manabu ;
Ota, Shuichi ;
Yoshida, Takeshi ;
Shimizu, Yuichi ;
Chuma, Makoto ;
Kawakami, Hiroshi ;
Asaka, Masahiro ;
Tanaka, Junji ;
Imamura, Masahiro ;
Kobayashi, Masanobu ;
Itoh, Hiroshi ;
Edamatsu, Hironori ;
Sutherland, Leslie C. ;
Brachmann, Rainer K. .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (02) :304-318